[1]钟婧捷,余振球.原发性高血压并脑小血管病患者的肾功能标志物及其他临床特点分析[J].医学信息,2023,36(19):118-121.[doi:10.3969/j.issn.1006-1959.2023.19.025]
　ZHONG Jing-jie,YU Zhen-qiu.Analysis of Renal Function Markers and Other Clinical Characteristics in Patients with Essential Hypertension and Cerebral Small Vessel Disease[J].Journal of Medical Information,2023,36(19):118-121.[doi:10.3969/j.issn.1006-1959.2023.19.025]
点击复制

原发性高血压并脑小血管病患者的肾功能标志物及其他临床特点分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年19期
页码:
118-121
栏目:
论著
出版日期:
2023-10-01

文章信息/Info

Title:
Analysis of Renal Function Markers and Other Clinical Characteristics in Patients with Essential Hypertension and Cerebral Small Vessel Disease
文章编号:
1006-1959（2023）19-0118-04
作者:
钟婧捷; 余振球
（贵州医科大学附属医院高血压科，贵州 贵阳 550004）
Author(s):
ZHONG Jing-jie; YU Zhen-qiu
(Department of Hypertension,Affiliated Hospital of Guizhou Medical University,Guiyang 550004,Guizhou,China)
关键词:
原发性高血压; 脑小血管病; 肾功能; 生物学标志物
Keywords:
Essential hypertension; Cerebral small vessel disease; Renal function; Biomarkers
分类号:
R743.2
DOI:
10.3969/j.issn.1006-1959.2023.19.025
文献标志码:
A
摘要:
目的 探讨原发性高血压患者肾功能生物学标志物及其他临床指标对其脑小血管病（CSVD）发生的影响。方法 选取2018年1月-2020年6月贵州医科大学附属医院高血压科286例住院的原发性高血压患者，根据头颅核磁共振检查结果分为CSVD组（178例），NCSVD组（108例）。比较两组血肌酐、尿酸、胱抑素C和尿微量蛋白/肌酐检测，并估测肾小球滤过率（e’GFR），对有差异指标行多因素Logistic回归分析，找出CSVD的独立危险因素。结果 两组尿微量蛋白/肌酐、血胱抑素C、e’GFR、年龄、体重、高血压病程、空腹血糖、血同型半胱氨酸水平比较，差异有统计学意义（P＜0.05）；Logistic回归分析显示，CSVD的独立危险因素包括年龄、空腹血糖（OR=1.112、1.337，P＜0.05）和体重，而体重是CSVD的保护因素（OR=0.959，P＜0.05）。结论 尿微量蛋白/肌酐、胱抑素C、e’GFR可作为原发性高血压患者预测CSVD的重点监测指标，而年龄越大、空腹血糖越高、体重越低，原发性高血压患者CSVD患病风险越高。
Abstract:
Objective To investigate the effect of biological markers of renal function and other clinical indicatorson on cerebral small-vessel disease (CSVD) in patients with primary hypertension.Methods A total of 286 patients with essential hypertension who were hospitalized in the Department of Hypertension, Affiliated Hospital of Guizhou Medical University from January 2018 to June 2020 were selected and divided into CSVD group (178 patients) and NCSVD group (108 patients) according to the results of cranial magnetic resonance imaging. Serum creatinine, uric acid, cystatin C and urinary microprotein/creatinine were compared between the two groups, and glomerular filtration rate (e’GFR) was estimated. Multivariate logistic regression analysis was performed on the different indicators to find out the independent risk factors of CSVD.Results There were significant differences in urinary microprotein/creatinine, serum cystatin C, e’GFR, age, weight, duration of hypertension, fasting blood glucose and blood homocysteine levels between the two groups (P＜0.05). Logistic regression analysis showed that age, fasting blood glucose (OR=1.112,1.337, P＜0.05) and body weight were independent risk factors for CSVD, while body weight was a protective factor for CSVD (OR=0.959, P＜0.05).Conclusion Urinary microprotein/creatinine, cystatin C, and e’GFR can be used as key monitoring indicators for predicting CSVD in patients with essential hypertension. The older the age, the higher the fasting blood glucose, and the lower the weight, the higher the risk of CSVD in patients with essential hypertension.

参考文献/References:

[1]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑小血管病诊治指南2020[J].中华神经科杂志,2022,55(8):807-818.[2]Thompson CS,Hakim AM.Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis[J].Stroke,2009,40(5):e322-e330.[3]Zhang JB,Liu LF,Li ZG,et al.Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients[J].Am J Hypertens,2015,28(6):739-745.[4]张申,任晓幸,刘扬.脑小血管病患者肾小球滤过率和微量白蛋白检测与认知功能的关系[J].中国现代医学杂志,2017,27(14):71-74.[5]孙岩,董艳华,张彩晓,等.血清胱抑素C水平与脑白质病变的关系的研究[J].中风与神经疾病杂志,2018,35(6):522-525.[6]张宇,孔令博,苗青,等.脑梗死患者肾小球滤过率预估值、胱抑素C水平与脑微出血的相关性分析[J].实用医院临床杂志,2019,16(6):44-47.[7]《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治,2019,19(1):1-44.[8]中华医学会老年医学分会老年神经病学组,脑小血管病认知功能障碍诊疗指南中国撰写专家组.脑小血管病相关认知功能障碍中国诊疗指南(2019)[J].中华老年医学杂志,2019,38(4):345-354.[9]Cacciapuoti F.Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties[J].J Thromb Thrombolysis,2011,32(1):82-88.[10]吴家成,郑小娟,胡小华,等.经脐三通道腹腔镜肾盂成形术治疗肾积水的效果及对肾功能的影响[J].医学信息,2022,35(8):112-114.[11]Pathania M,Rathaur VK,Yadav N,et al.Quantitative Micro-albuminuria Assessment from ’Random Voided Urinary Albumin: Creatinine Ratio’ Versus ’24 hours Urinary Albumin Concentration’ for Screening of Diabetic Nephropathy[J].J Clin Diagn Res,2013,7(12):2828-2831.[12]Mussap M,Plebani M.Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci,2004,41(5-6):467-550.[13]Arpeg?覽rd J,Magnusson P,Chen X,et al.Cystatin C Predicts Incident Cardiovascular Disease in Twins[J].J Am Heart Assoc,2016,5(6):e003085.[14]张新奇,张杰文,黄月.血清胱抑素C水平与脑小血管病关系的研究[J].中国实用神经疾病杂志,2018,21(21):2356-2360.[15]张涛,陈伟.中青年高血压患者脑微出血危险因素分析[J].心脑血管病防治,2019,19(5):432-434.[16]Ryu WS,Kim CK,Kim BJ,et al.Serum uric acid levels and cerebral microbleeds in patients with acute ischemic stroke[J].PLoS One,2013,8(1):e55210.[17]Yang S,Zhang X,Yuan J,et al.Serum Uric Acid is Independently Associated with Enlarged Perivascular Spaces[J].Sci Rep,2017,7(1):16435.[18]王维维,申致远,李凡,等.高血压病合并脑小血管病的危险因素及与认知功能的关系[J].中国神经精神疾病杂志,2022,48(7):392-397.[19]张涛,陈伟.中青年高血压患者脑微出血危险因素分析[J].心脑血管病防治,2019,19(5):432-434.[20]Andersen KK,Olsen TS.The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients[J].Int J Stroke,2015,10(1):99-104.

相似文献/References:

[1]段淑婷,王义围,王兆鹏.高血压病合并糖调节受损患者血压变异性的相关研究[J].医学信息,2018,31(05):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
　DUAN Shu-ting,WANG Yi-wei,WANG Zhao-peng.Study on Blood Pressure Variability in Patients with Hypertension Complicated with Impaired Glucose Regulation[J].Journal of Medical Information,2018,31(19):11.[doi:10.3969/j.issn.1006-1959.2018.05.004]
[2]韩 倩,刘 兴.脑小血管病诊疗进展[J].医学信息,2018,31(11):52.[doi:10.3969/j.issn.1006-1959.2018.11.017]
　HAN Qian,LIU Xing.Progress in Diagnosis and Treatment of Small Cerebral Vascular Disease[J].Journal of Medical Information,2018,31(19):52.[doi:10.3969/j.issn.1006-1959.2018.11.017]
[3]张 伟.动态血压监测不同剂型硝苯地平在原发性高血压患者中的治疗效果[J].医学信息,2022,35(10):152.[doi:10.3969/j.issn.1006-1959.2022.10.038]
　ZHANG Wei.Effect of Different Dosage Forms of Nifedipine on Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension[J].Journal of Medical Information,2022,35(19):152.[doi:10.3969/j.issn.1006-1959.2022.10.038]
[4]李信明,刘春梅,任正强,等.供需平衡视角下原发性高血压的病机与防治[J].医学信息,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
　LI Xin-Ming,LIU Chun-Mei,REN Zheng-Qiang,et al.Pathogenesis and Prevention of Essential Hypertension from the Perspective of Supply and Demand Balance[J].Journal of Medical Information,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.19.058]
[5]穆大明.厄贝沙坦氢氯噻嗪与福辛普利治疗原发性高血压的疗效观察[J].医学信息,2019,32(03):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
　MU Da-ming.Efficacy of Irbesartan Hydrochlorothiazide and Fosinopril in the Treatment of Essential Hypertension[J].Journal of Medical Information,2019,32(19):151.[doi:10.3969/j.issn.1006-1959.2019.03.049]
[6]袁秀萍.高压氧联合尼莫地平治疗脑小血管病所致 认知功能障碍的疗效评价[J].医学信息,2019,32(17):79.[doi:10.3969/j.issn.1006-1959.2019.17.024]
　YUAN Xiu-ping.Efficacy Evaluation of Hyperbaric Oxygen Combined with Nimodipine in the Treatment of Cognitive Dysfunction Caused by Cerebral Small Vessel Disease[J].Journal of Medical Information,2019,32(19):79.[doi:10.3969/j.issn.1006-1959.2019.17.024]
[7]熊依良.奥美沙坦酯氢氯噻嗪片治疗轻中度原发性高血压的疗效及安全性分析[J].医学信息,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
　XIONG Yi-liang.Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Tablets in the Treatment of Mild to Moderate Essential Hypertension[J].Journal of Medical Information,2018,31(19):142.[doi:10.3969/j.issn.1006-1959.2018.19.043]
[8]郑艳芳,郭军霞,张永春.原发性高血压合并阵发性心房颤动的危险因素分析[J].医学信息,2021,34(22):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]
　ZHENG Yan-fang,GUO Jun-xia,ZHANG Yong-chun.Risk Factors Analysis of Essential Hypertension Complicated with Paroxysmal Atrial Fibrillation[J].Journal of Medical Information,2021,34(19):51.[doi:10.3969/j.issn.1006-1959.2021.22.014]
[9]潘建鑫.高血压患者血小板/淋巴细胞比值与颈动脉粥样硬化的相关性分析[J].医学信息,2020,33(05):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
　Pan Jianxin.Correlation analysis of platelet/lymphocyte ratio and carotid atherosclerosisin patients with primary hypertension[J].Journal of Medical Information,2020,33(19):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
[10]谢祥红.AngⅡ、ET-1对高血压患者病情发生发展的影响[J].医学信息,2020,33(16):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]
　XIE Xiang-hong.Effects of AngⅡ and ET-1 on the Occurrence and Development of Hypertension Patients[J].Journal of Medical Information,2020,33(19):75.[doi:10.3969/j.issn.1006-1959.2020.16.023]

更新日期/Last Update: 1900-01-01